M
$ Value
$42K
Shares
8,220
Price
$5
Filed
May 23
Insider
Name
Andrade Robert
Title
CHIEF FINANCIAL OFFICER
CIK
0001468308
Roles
Officer
Transaction Details
Transaction Date
2025-05-22
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
850,751
Footnotes
Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027.
Filing Info
Andrade Robert's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | FENC | M | $0 |
| 2026-03-31 | FENC | M | $0 |
| 2026-03-31 | FENC | A | $692K |
| 2026-03-28 | FENC | M | $0 |
| 2026-03-26 | FENC | M | $67K |
| 2026-03-26 | FENC | M | $67K |
| 2026-02-28 | FENC | A | $0 |
| 2026-02-18 | FENC | M | $10K |
| 2026-02-18 | FENC | M | $0 |
| 2026-02-18 | FENC | M | $10K |
Other Insiders at FENC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Andrade Robert
CHIEF FINANCIAL OFFICER
|
— | — | 2026-03-31 |
| Raykov Rosty | — | $234K | 2026-04-01 |
|
Hackman Jeffrey S.
Chief Executive Officer
|
— | — | 2026-03-31 |
|
Evans Terry L
Chief Commercial Officer
|
— | — | 2026-03-31 |
|
Sayad Pierre Sargis
Chief Medical Officer
|
— | — | 2026-03-31 |
|
Cioffi Christiana Marie
Chief Strategy Officer
|
— | — | 2026-03-31 |